Antiamoebic drugs for treating amoebic colitis (Q24241818)

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Efficacy and Safety of Quinfamide versus Secnidazole in the Management of Amoebic Non-Dysenteric Colitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Treatment of children with acute amoebic dysentery. Comparative trial of metronidazole against a combination of dehydroemetine, tetracycline, and diloxanide furoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Short course of Single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis a Comparative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Imidazole and metronidazole in the treatment of intestinal amoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Treatment of asymptomatic intestinal Entamoeba histolytica infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Treatment of intestinal amoebiasis with diloxanide furoate, tetracycline and chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Niridazole in amebic dysentery and hepatic amebiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Comparative study of tinidazole and metronidazole in amoebic liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Pharmacokinetic Evaluation of Guar Gum-Based Colon-Targeted Drug Delivery Systems of Tinidazole in Healthy Human Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Paromomycin in the treatment of mild-to-moderate intestinal amebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

The salutary effect of milk on amoebiasis and its reversal by iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Randomized, single-blind, placebo-controlled multicenter trial to compare the efficacy and safety of metronidazole and satranidazole in patients with amebic liver abscess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

The use of niridazole alone and in combination with other amoebicides in amoebic dysentery and amoebic liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Chloroquine in amoebic dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Emetine hydrochloride and dehydroemetine combined with chloroquine in the treatment of children with amoebic liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Metronidazole and Niridazole combined with Dehydroemetine in Treatment of Children with Amoebic Liver Abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Needle aspiration of amoebic liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Nondysenteric intestinal amebiasis. Treatment with diloxanide furoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Seroepidemiology of Entamoeba histolytica in a slum in northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Necrotizing amebic colitis: a frequently fatal complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Innate and acquired resistance to amebiasis in bangladeshi children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Entamoeba histolytica infection in children and protection from subsequent amebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

The chemotherapy of amoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Amebic perforation of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Diagnosis and management of amebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Estimating the impact of amebiasis on health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Metronidazole in amoebic dysentery and amoebic liver abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Short-term follow-up studies in amoebic dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

New developments in the therapy of amoebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Prevalence and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Laboratory diagnosis of amebiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Comparison of two methods (microscopy and enzyme-linked immunosorbent assay) for the diagnosis of amebiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from the tropics and male homosexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Special Topics in Statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

A clinical trial of 1-dichloroacetyl-4-methylpiperidine (R.D. 7098) a new anti-amoebic drug

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Clinical trial of oral dehydroemetine in intestinal amoebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Amoebiasis: clinical trials of dehydroemetine late-release tablets (Ro 1-9334-20) compared with parenteral dehydroemetine and niridazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Treatment of non-invasive amoebiasis. A comparison between tinidazole alone and in combination with diloxanide furoate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Nitazoxanide in the treatment of amoebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

The Presentation of Amoebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Ambilhar in amoebic dysentery and amoebic liver abscess

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Latest developments in the treatment of amebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Paromomycin in acute amoebic dysentery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

DEHYDROEMETINE IN THE TREATMENT OF AMOEBIC LIVER ABSCESS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

A comparative trial of dehydroemetine, emetine hydrochloride and chloroquine in the treatment of amoebic liver abscess

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

THE TREATMENT OF ACUTE AMOEBIC DYSENTERY: TRIALS OF DEHYDROEMETINE, OF DEHYDROEMETINE-BISMUTH-IODIDE, AND OF DEHYDROEMETINE AND DEHYDROEMETINE-BISMUTH-IODIDE IN COMBINATION

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

A comparative trial of dehydroemetine and emetine hydrochloride in identical dosage in amoebic liver abscess

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Single and low dosage regimens of metronidazole in amoebic dysentery and amoebic liver abscess.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Single-dose and short course regimens of metronidazole in the treatment of amoebiasis in Malaysia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Treatment of non-invasive amoebiasis--a comparison between tinidazole and metronidazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Amoebic liver abscess: the effect of aspiration on the resolution or healing time

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Amebic colitis. Preventing morbidity and mortality from fulminant disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Invasive amebiasis. I. Amebic dysentery and its complications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Treatment of asymptomatic amebiasis in homosexual men. Clinical trials with metronidazole, tinidazole, and diloxanide furoate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Efficacy of niridazole in amoebic dysentery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Seropositivity for and intestinal colonization with Entamoeba histolytica and entamoeba dispar in individuals in northeastern Brazil

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Tissue damage in haemochromatosis: an analysis of the roles of iron and alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Ornidazole and secnidazole in the treatment of symptomatic intestinal amoebiasis in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Efficacy of a combined diloxanide furoate-metronidazole preparation in the treatment of amoebiasis and giardiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

A Comparative Study of Tinidazole and Metronidazole as a Single Daily Dose for Three Days in Symptomatic Intestinal Amoebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Treatment of Amoebic Liver Abscess with Tinidazole and Metronidazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

The Effect of a Nitro-Thiazole Derivative, Ciba 32,644-Ba, in Amebic Dysentery and Amebic Liver Abscess

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Intestinal amebiasis. A preliminary clinical trial of furamide T-c.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Evaluation of metronidazole and MK-910 in invasive amebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Some new nitroimidazole derivatives. Clinical trials in amebic liver abscess

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Double blind study with a new nitroimidazole derivative, Ro 7-0207, versus metronidazole in symptomatic intestinal amebiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the northern Philippines as detected by the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021

Prevalence and species distribution of E. Histolytica and E. Dispar in the Venda region, Limpopo, South Africa.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006085.PUB2

7 January 2021